サマリー

COVID-19の流行により、COVID-19迅速抗原検査キットの世界市場規模は2022年に615億9158万米ドルと推定され、2028年には141億5420万米ドルの再調整規模になると予測され、予測期間2022-2028年にはCAGRが-21.74%で推移すると予測されています。この健康危機による経済変化を十分に考慮し、2021年にCOVID-19迅速抗原検査キット世界市場の81.12％を占める蛍光イムノクロマトは、2028年までに112億2711万米ドルの価値を持ち、2022年から2028年まで改訂-19.86％のCAGRで成長すると予測されています。一方、病院分野は、この予測期間中、CAGRが-20.53%に変更されています。
北米のCOVID-19迅速抗原検査キット市場規模は2021年に76億7,309万米ドル、欧州は127億2,208万米ドルでした。2021年の北米の割合は27.38％、欧州の割合は45.38％で、欧州の市場シェアは2028年には24.64％に達し、分析期間を通じてCAGR-23.12％をたどると予測されています。

COVID-19 Rapid Antigen Test Kitsの世界の主要メーカーは、Abbott、ROCHE、SD Biosensor、Orient Gene、BD、Quidel、Beijing Hotgen Biotech、ACON Biotech、Celltrion、Jinwofu Bioengineering Technology、LumiraDx、ACCESS BIO.などが挙げられます。EasyDiagnosis Biomedicine、Ellume、Wantai BioPharm、Clip Health、Hangzhou AllTest Biotech、Ihealth (Andon Health)、Biotest Biotech、Phase Scientific、BGI Genomics、Wondfo Biotech、Assure Tech、Lepu Medical Technology、RapiGEN Inc.,などです。収益面では、2021年のCOVID-19迅速抗原検査キットの市場シェアは、世界3大企業が37.29％を占めています。
本レポートは、世界レベル、地域レベル、企業レベルでのCOVID-19迅速抗原検査キットの数量と価値に焦点を当てています。グローバルな視点から、過去のデータと将来の見通しを分析し、COVID-19迅速抗原検査キットの全体的な市場規模を表しています。

COVID-19迅速抗原検査キットの世界市場。セグメント分析
この調査レポートには、地域（国）別、企業別、タイプ別、用途別の具体的なセグメントが含まれています。2020年から2028年までの歴史的期間と予測期間における売上高と収益に関する情報を提供します。セグメントを理解することは、市場成長を助ける様々な要因の重要性を特定するのに役立ちます。

世界のCOVID-19迅速抗原検査キット市場。セグメント分析
この調査レポートは、地域（国）別、メーカー別、タイプ別、用途別の具体的なセグメントを含んでいます。各タイプは、2020年から2028年の予測期間中の生産に関する情報を提供します。アプリケーション別セグメントでは、2020年から2028年の予測期間中の消費も提供します。セグメントを理解することは、市場の成長を助けるさまざまな要因の重要性を特定するのに役立ちます。

企業別
アボット社
クワイデル
アクセスバイオ
CTKバイオテック
SDバイオセンサー
エルム
インビオ
セルトリオン
エスキューブグループ
ROCHE
BD
オラシュア・テクノロジーズ
クリップヘルス
ルミラデックス
プリンストン・バイオメディカル・コーポレーション
ラピジェン株式会社
オリエントジーン
ウォンドフォ・バイオテック
Ihealth (アンドン・ヘルス)
ワンタイバイオファーマ
ビオテスト・バイオテック
深圳YHLOバイオテック
Vazymeバイオテック
易診生物医学
北京ホトゲン生物技術有限公司
アシュアテック
杭州万達生物技術有限公司
アコンバイオテック
BGIジェノミクス
乐普医療技術
金沃福生物工学技術
フェーズサイエンティフィック

タイプ別セグメント
蛍光イムノクロマトグラフィー
コロイド金イムノクロマトグラフィー
ラテックスイムノクロマトグラフィー
その他

用途別セグメント
病院
家庭
学校
第三者検査機関
その他

地域別消費量
北アメリカ
米国
カナダ

アジア太平洋地域
中国
日本
韓国
インド
オーストラリア
東南アジア
その他の地域

ヨーロッパ
ドイツ
英国
フランス
イタリア
ロシア
その他の欧州

中南米
メキシコ
ブラジル
アルゼンチン
コロンビア
ラテンアメリカの残りの部分

中近東・アフリカ
トルコ
サウジアラビア
U.A.E.
その他の地域

ページTOPに戻る

目次

1 COVID-19 RAPID ANTIGEN TEST KITS MARKET OVERVIEW 1
1.1 PRODUCT OVERVIEW AND SCOPE OF COVID-19 RAPID ANTIGEN TEST KITS 1
1.2 COVID-19 RAPID ANTIGEN TEST KITS SEGMENT BY TYPE 1
1.2.1 GLOBAL COVID-19 RAPID ANTIGEN TEST KITS SALES GROWTH RATE COMPARISON BY TYPE (2022-2028) 2
1.2.2 FLUORESCENCE IMMUNOCHROMATOGRAPHY 3
1.2.3 COLLOIDAL GOLD IMMUNOCHROMATOGRAPHY 4
1.2.4 LATEX IMMUNOCHROMATOGRAPHY 5
1.3 COVID-19 RAPID ANTIGEN TEST KITS SEGMENT BY APPLICATION 6
1.3.1 GLOBAL COVID-19 RAPID ANTIGEN TEST KITS SALES COMPARISON BY APPLICATION (2022-2028) 6
1.3.2 HOSPITAL 7
1.3.3 HOME 8
1.3.4 SCHOOL 9
1.3.5 THIRD-PARTY DETECTION INSTITUTION 10
1.4 GLOBAL COVID-19 RAPID ANTIGEN TEST KITS MARKET SIZE ESTIMATES AND FORECASTS 11
1.4.1 GLOBAL COVID-19 RAPID ANTIGEN TEST KITS REVENUE 2020-2028 11
1.4.2 GLOBAL COVID-19 RAPID ANTIGEN TEST KITS SALES 2020-2028 13
1.4.3 COVID-19 RAPID ANTIGEN TEST KITS MARKET SIZE BY REGION: 2020 VERSUS 2021 VERSUS 2028 13
2 COVID-19 RAPID ANTIGEN TEST KITS MARKET COMPETITION BY MANUFACTURERS 14
2.1 GLOBAL COVID-19 RAPID ANTIGEN TEST KITS SALES MARKET SHARE BY MANUFACTURERS (2020-2022) 14
2.2 GLOBAL COVID-19 RAPID ANTIGEN TEST KITS REVENUE MARKET SHARE BY MANUFACTURERS (2020-2022) 19
2.3 GLOBAL COVID-19 RAPID ANTIGEN TEST KITS AVERAGE PRICE BY MANUFACTURERS (2020-2022) 23
2.4 MANUFACTURERS COVID-19 RAPID ANTIGEN TEST KITS HEADQUARTERS, AREA SERVED, PRODUCT TYPE 24
2.5 COVID-19 RAPID ANTIGEN TEST KITS MARKET COMPETITIVE SITUATION AND TRENDS 26
2.5.1 COVID-19 RAPID ANTIGEN TEST KITS MARKET CONCENTRATION RATE 26
2.5.2 THE GLOBAL 5 AND 10 LARGEST COVID-19 RAPID ANTIGEN TEST KITS PLAYERS MARKET SHARE BY REVENUE 27
2.5.3 GLOBAL COVID-19 RAPID ANTIGEN TEST KITS MARKET SHARE BY COMPANY TYPE (TIER 1, TIER 2, AND TIER 3) 28
2.6 MANUFACTURERS MERGERS & ACQUISITIONS, EXPANSION PLANS 29
3 COVID-19 RAPID ANTIGEN TEST KITS RETROSPECTIVE MARKET SCENARIO BY REGION 34
3.1 GLOBAL COVID-19 RAPID ANTIGEN TEST KITS RETROSPECTIVE MARKET SCENARIO IN SALES BY REGION: 2020-2022 34
3.2 GLOBAL COVID-19 RAPID ANTIGEN TEST KITS RETROSPECTIVE MARKET SCENARIO IN REVENUE BY REGION: 2020-2022 34
3.3 NORTH AMERICA COVID-19 RAPID ANTIGEN TEST KITS MARKET FACTS & FIGURES BY COUNTRY 35
3.3.1 NORTH AMERICA COVID-19 RAPID ANTIGEN TEST KITS SALES BY COUNTRY 35
3.3.2 NORTH AMERICA COVID-19 RAPID ANTIGEN TEST KITS REVENUE BY COUNTRY 36
3.3.3 UNITED STATES 37
3.3.4 CANADA 38
3.4 EUROPE COVID-19 RAPID ANTIGEN TEST KITS MARKET FACTS & FIGURES BY COUNTRY 38
3.4.1 EUROPE COVID-19 RAPID ANTIGEN TEST KITS SALES BY COUNTRY 38
3.4.2 EUROPE COVID-19 RAPID ANTIGEN TEST KITS REVENUE BY COUNTRY 39
3.4.3 GERMANY 41
3.4.4 FRANCE 41
3.4.5 U.K. 42
3.4.6 ITALY 43
3.4.7 RUSSIA 43
3.5 ASIA PACIFIC COVID-19 RAPID ANTIGEN TEST KITS MARKET FACTS & FIGURES BY REGION 44
3.5.1 ASIA PACIFIC COVID-19 RAPID ANTIGEN TEST KITS SALES BY REGION 44
3.5.2 ASIA PACIFIC COVID-19 RAPID ANTIGEN TEST KITS REVENUE BY REGION 45
3.5.3 CHINA 47
3.5.4 JAPAN 47
3.5.5 SOUTH KOREA 48
3.5.6 INDIA 49
3.5.7 AUSTRALIA 49
3.5.8 SOUTHEAST ASIA 50
3.6 LATIN AMERICA COVID-19 RAPID ANTIGEN TEST KITS MARKET FACTS & FIGURES BY COUNTRY 50
3.6.1 LATIN AMERICA COVID-19 RAPID ANTIGEN TEST KITS SALES BY COUNTRY 50
3.6.2 LATIN AMERICA COVID-19 RAPID ANTIGEN TEST KITS REVENUE BY COUNTRY 51
3.6.3 BRAZIL 53
3.6.4 MEXICO 53
3.6.5 ARGENTINA 54
3.6.6 COLOMBIA 55
3.7 MIDDLE EAST AND AFRICA COVID-19 RAPID ANTIGEN TEST KITS MARKET FACTS & FIGURES BY COUNTRY 55
3.7.1 MIDDLE EAST AND AFRICA COVID-19 RAPID ANTIGEN TEST KITS SALES BY COUNTRY 55
3.7.2 MIDDLE EAST AND AFRICA COVID-19 RAPID ANTIGEN TEST KITS REVENUE BY COUNTRY 56
3.7.3 TURKEY 58
3.7.4 SAUDI ARABIA 58
3.7.5 UAE 59
4 COVID-19 RAPID ANTIGEN TEST KITS HISTORIC MARKET ANALYSIS BY TYPE 60
4.1 GLOBAL COVID-19 RAPID ANTIGEN TEST KITS SALES MARKET SHARE BY TYPE (2020-2022) 60
4.2 GLOBAL COVID-19 RAPID ANTIGEN TEST KITS REVENUE MARKET SHARE BY TYPE (2020-2022) 61
4.3 GLOBAL COVID-19 RAPID ANTIGEN TEST KITS PRICE BY TYPE (2020-2022) 62
5 COVID-19 RAPID ANTIGEN TEST KITS HISTORIC MARKET ANALYSIS BY APPLICATION 63
5.1 GLOBAL COVID-19 RAPID ANTIGEN TEST KITS SALES MARKET SHARE BY APPLICATION (2020-2022) 63
5.2 GLOBAL COVID-19 RAPID ANTIGEN TEST KITS REVENUE MARKET SHARE BY APPLICATION (2020-2022) 64
5.3 GLOBAL COVID-19 RAPID ANTIGEN TEST KITS PRICE BY APPLICATION (2020-2022) 65
6 KEY COMPANIES PROFILED 67
6.1 ABBOTT 67
6.1.1 ABBOTT CORPORATION INFORMATION 67
6.1.2 ABBOTT DESCRIPTION AND BUSINESS OVERVIEW 68
6.1.3 ABBOTT COVID-19 RAPID ANTIGEN TEST KITS SALES, REVENUE AND GROSS MARGIN (2020-2022) 68
6.1.4 ABBOTT COVID-19 RAPID ANTIGEN TEST KITS PRODUCT PORTFOLIO 69
6.1.5 ABBOTT RECENT DEVELOPMENTS/UPDATES 70
6.2 QUIDEL 71
6.2.1 QUIDEL CORPORATION INFORMATION 71
6.2.2 QUIDEL DESCRIPTION AND BUSINESS OVERVIEW 71
6.2.3 QUIDEL COVID-19 RAPID ANTIGEN TEST KITS SALES, REVENUE AND GROSS MARGIN (2020-2022) 72
6.2.4 QUIDEL COVID-19 RAPID ANTIGEN TEST KITS PRODUCT PORTFOLIO 73
6.2.5 QUIDEL RECENT DEVELOPMENTS/UPDATES 76
6.3 ACCESS BIO 77
6.3.1 ACCESS BIO CORPORATION INFORMATION 77
6.3.2 ACCESS BIO DESCRIPTION AND BUSINESS OVERVIEW 78
6.3.3 ACCESS BIO COVID-19 RAPID ANTIGEN TEST KITS SALES, REVENUE AND GROSS MARGIN (2020-2022) 78
6.3.4 ACCESS BIO COVID-19 RAPID ANTIGEN TEST KITS PRODUCT PORTFOLIO 78
6.4 CTK BIOTECH 80
6.4.1 CTK BIOTECH CORPORATION INFORMATION 80
6.4.2 CTK BIOTECH DESCRIPTION AND BUSINESS OVERVIEW 81
6.4.3 CTK BIOTECH COVID-19 RAPID ANTIGEN TEST KITS SALES, REVENUE AND GROSS MARGIN (2020-2022) 82
6.4.4 CTK BIOTECH COVID-19 RAPID ANTIGEN TEST KITS PRODUCT PORTFOLIO 82
6.4.5 CTK BIOTECH RECENT DEVELOPMENTS/UPDATES 83
6.5 SD BIOSENSOR 84
6.5.1 SD BIOSENSOR CORPORATION INFORMATION 84
6.5.2 SD BIOSENSOR DESCRIPTION AND BUSINESS OVERVIEW 84
6.5.3 SD BIOSENSOR COVID-19 RAPID ANTIGEN TEST KITS SALES, REVENUE AND GROSS MARGIN (2020-2022) 85
6.5.4 SD BIOSENSOR COVID-19 RAPID ANTIGEN TEST KITS PRODUCT PORTFOLIO 85
6.6 ELLUME 87
6.6.1 ELLUME CORPORATION INFORMATION 87
6.6.2 ELLUME DESCRIPTION AND BUSINESS OVERVIEW 88
6.6.3 ELLUME COVID-19 RAPID ANTIGEN TEST KITS SALES, REVENUE AND GROSS MARGIN (2020-2022) 88
6.6.4 ELLUME COVID-19 RAPID ANTIGEN TEST KITS PRODUCT PORTFOLIO 88
6.6.5 ELLUME RECENT DEVELOPMENTS/UPDATES 90
6.7 INBIOS 90
6.7.1 INBIOS CORPORATION INFORMATION 90
6.7.2 INBIOS DESCRIPTION AND BUSINESS OVERVIEW 91
6.7.3 INBIOS COVID-19 RAPID ANTIGEN TEST KITS SALES, REVENUE AND GROSS MARGIN (2020-2022) 92
6.7.4 INBIOS COVID-19 RAPID ANTIGEN TEST KITS PRODUCT PORTFOLIO 92
6.8 CELLTRION 93
6.8.1 CELLTRION CORPORATION INFORMATION 93
6.8.2 CELLTRION DESCRIPTION AND BUSINESS OVERVIEW 94
6.8.3 CELLTRION COVID-19 RAPID ANTIGEN TEST KITS SALES, REVENUE AND GROSS MARGIN (2020-2022) 95
6.8.4 CELLTRION COVID-19 RAPID ANTIGEN TEST KITS PRODUCT PORTFOLIO 95
6.8.5 CELLTRION RECENT DEVELOPMENTS/UPDATES 96
6.9 AESKU.GROUP 97
6.9.1 AESKU.GROUP CORPORATION INFORMATION 97
6.9.2 AESKU.GROUP DESCRIPTION AND BUSINESS OVERVIEW 98
6.9.3 AESKU.GROUP COVID-19 RAPID ANTIGEN TEST KITS SALES, REVENUE AND GROSS MARGIN (2020-2022) 98
6.9.4 AESKU.GROUP COVID-19 RAPID ANTIGEN TEST KITS PRODUCT PORTFOLIO 99
6.9.5 AESKU.GROUP RECENT DEVELOPMENTS/UPDATES 100
6.10 ROCHE 101
6.10.1 ROCHE CORPORATION INFORMATION 101
6.10.2 ROCHE DESCRIPTION AND BUSINESS OVERVIEW 101
6.10.3 ROCHE COVID-19 RAPID ANTIGEN TEST KITS SALES, REVENUE AND GROSS MARGIN (2020-2022) 102
6.10.4 ROCHE COVID-19 RAPID ANTIGEN TEST KITS PRODUCT PORTFOLIO 102
6.10.5 ROCHE RECENT DEVELOPMENTS/UPDATES 104
6.11 BD 104
6.11.1 BD CORPORATION INFORMATION 104
6.11.2 BD DESCRIPTION AND BUSINESS OVERVIEW 105
6.11.3 BD COVID-19 RAPID ANTIGEN TEST KITS SALES, REVENUE AND GROSS MARGIN (2020-2022) 106
6.11.4 BD COVID-19 RAPID ANTIGEN TEST KITS PRODUCT PORTFOLIO 106
6.11.5 BD RECENT DEVELOPMENTS/UPDATES 107
6.12 ORASURE TECHNOLOGIES 108
6.12.1 ORASURE TECHNOLOGIES CORPORATION INFORMATION 108
6.12.2 ORASURE TECHNOLOGIES DESCRIPTION AND BUSINESS OVERVIEW 109
6.12.3 ORASURE TECHNOLOGIES COVID-19 RAPID ANTIGEN TEST KITS SALES, REVENUE AND GROSS MARGIN (2020-2022) 109
6.12.4 ORASURE TECHNOLOGIES COVID-19 RAPID ANTIGEN TEST KITS PRODUCT PORTFOLIO 110
6.12.5 ORASURE TECHNOLOGIES RECENT DEVELOPMENTS/UPDATES 111
6.13 CLIP HEALTH 112
6.13.1 CLIP HEALTH CORPORATION INFORMATION 112
6.13.2 CLIP HEALTH DESCRIPTION AND BUSINESS OVERVIEW 113
6.13.3 CLIP HEALTH COVID-19 RAPID ANTIGEN TEST KITS SALES, REVENUE AND GROSS MARGIN (2020-2022) 113
6.13.4 CLIP HEALTH COVID-19 RAPID ANTIGEN TEST KITS PRODUCT PORTFOLIO 114
6.14 LUMIRADX 116
6.14.1 LUMIRADX CORPORATION INFORMATION 116
6.14.2 LUMIRADX DESCRIPTION AND BUSINESS OVERVIEW 116
6.14.3 LUMIRADX COVID-19 RAPID ANTIGEN TEST KITS SALES, REVENUE AND GROSS MARGIN (2020-2022) 117
6.14.4 LUMIRADX COVID-19 RAPID ANTIGEN TEST KITS PRODUCT PORTFOLIO 117
6.14.5 LUMIRADX RECENT DEVELOPMENTS/UPDATES 121
6.15 PRINCETON BIOMEDITECH 121
6.15.1 PRINCETON BIOMEDITECH CORPORATION INFORMATION 121
6.15.2 PRINCETON BIOMEDITECH DESCRIPTION AND BUSINESS OVERVIEW 122
6.15.3 PRINCETON BIOMEDITECH COVID-19 RAPID ANTIGEN TEST KITS SALES, REVENUE AND GROSS MARGIN (2020-2022) 122
6.15.4 PRINCETON BIOMEDITECH COVID-19 RAPID ANTIGEN TEST KITS PRODUCT PORTFOLIO 123
6.16 RAPIGEN INC. 124
6.16.1 RAPIGEN INC. CORPORATION INFORMATION 124
6.16.2 RAPIGEN INC. DESCRIPTION AND BUSINESS OVERVIEW 124
6.16.3 RAPIGEN INC. COVID-19 RAPID ANTIGEN TEST KITS SALES, REVENUE AND GROSS MARGIN (2020-2022) 125
6.16.4 RAPIGEN INC. COVID-19 RAPID ANTIGEN TEST KITS PRODUCT PORTFOLIO 125
6.17 ORIENT GENE 127
6.17.1 ORIENT GENE CORPORATION INFORMATION 127
6.17.2 ORIENT GENE DESCRIPTION AND BUSINESS OVERVIEW 128
6.17.3 ORIENT GENE COVID-19 RAPID ANTIGEN TEST KITS SALES, REVENUE AND GROSS MARGIN (2020-2022) 128
6.17.4 ORIENT GENE COVID-19 RAPID ANTIGEN TEST KITS PRODUCT PORTFOLIO 129
6.18 WONDFO BIOTECH 130
6.18.1 WONDFO BIOTECH CORPORATION INFORMATION 130
6.18.2 WONDFO BIOTECH DESCRIPTION AND BUSINESS OVERVIEW 131
6.18.3 WONDFO BIOTECH COVID-19 RAPID ANTIGEN TEST KITS SALES, REVENUE AND GROSS MARGIN (2020-2022) 132
6.18.4 WONDFO BIOTECH COVID-19 RAPID ANTIGEN TEST KITS PRODUCT PORTFOLIO 132
6.19 IHEALTH (ANDON HEALTH) 134
6.19.1 IHEALTH (ANDON HEALTH) CORPORATION INFORMATION 134
6.19.2 IHEALTH (ANDON HEALTH) DESCRIPTION AND BUSINESS OVERVIEW 135
6.19.3 IHEALTH (ANDON HEALTH) COVID-19 RAPID ANTIGEN TEST KITS SALES, REVENUE AND GROSS MARGIN (2020-2022) 136
6.19.4 IHEALTH (ANDON HEALTH) COVID-19 RAPID ANTIGEN TEST KITS PRODUCT PORTFOLIO 136
6.19.5 IHEALTH (ANDON HEALTH) RECENT DEVELOPMENTS/UPDATES 138
6.20 WANTAI BIOPHARM 139
6.20.1 WANTAI BIOPHARM CORPORATION INFORMATION 139
6.20.2 WANTAI BIOPHARM DESCRIPTION AND BUSINESS OVERVIEW 140
6.20.3 WANTAI BIOPHARM COVID-19 RAPID ANTIGEN TEST KITS SALES, REVENUE AND GROSS MARGIN (2020-2022) 141
6.20.4 WANTAI BIOPHARM COVID-19 RAPID ANTIGEN TEST KITS PRODUCT PORTFOLIO 141
6.21 BIOTEST BIOTECH 143
6.21.1 BIOTEST BIOTECH CORPORATION INFORMATION 143
6.21.2 BIOTEST BIOTECH DESCRIPTION AND BUSINESS OVERVIEW 143
6.21.3 BIOTEST BIOTECH COVID-19 RAPID ANTIGEN TEST KITS SALES, REVENUE AND GROSS MARGIN (2020-2022) 144
6.21.4 BIOTEST BIOTECH COVID-19 RAPID ANTIGEN TEST KITS PRODUCT PORTFOLIO 145
6.21.5 BIOTEST BIOTECH RECENT DEVELOPMENTS/UPDATES 149
6.22 SHENZHEN YHLO BIOTECH 149
6.22.1 SHENZHEN YHLO BIOTECH CORPORATION INFORMATION 149
6.22.2 SHENZHEN YHLO BIOTECH DESCRIPTION AND BUSINESS OVERVIEW 150
6.22.3 SHENZHEN YHLO BIOTECH COVID-19 RAPID ANTIGEN TEST KITS SALES, REVENUE AND GROSS MARGIN (2020-2022) 151
6.22.4 SHENZHEN YHLO BIOTECH COVID-19 RAPID ANTIGEN TEST KITS PRODUCT PORTFOLIO 151
6.22.5 SHENZHEN YHLO BIOTECH RECENT DEVELOPMENTS/UPDATES 152
6.23 VAZYME BIOTECH 154
6.23.1 VAZYME BIOTECH CORPORATION INFORMATION 154
6.23.2 VAZYME BIOTECH DESCRIPTION AND BUSINESS OVERVIEW 154
6.23.3 VAZYME BIOTECH COVID-19 RAPID ANTIGEN TEST KITS SALES, REVENUE AND GROSS MARGIN (2020-2022) 155
6.23.4 VAZYME BIOTECH COVID-19 RAPID ANTIGEN TEST KITS PRODUCT PORTFOLIO 155
6.23.5 VAZYME BIOTECH RECENT DEVELOPMENTS/UPDATES 157
6.24 EASYDIAGNOSIS BIOMEDICINE 158
6.24.1 EASYDIAGNOSIS BIOMEDICINE CORPORATION INFORMATION 158
6.24.2 EASYDIAGNOSIS BIOMEDICINE DESCRIPTION AND BUSINESS OVERVIEW 159
6.24.3 EASYDIAGNOSIS BIOMEDICINE COVID-19 RAPID ANTIGEN TEST KITS SALES, REVENUE AND GROSS MARGIN (2020-2022) 159
6.24.4 EASYDIAGNOSIS BIOMEDICINE COVID-19 RAPID ANTIGEN TEST KITS PRODUCT PORTFOLIO 159
6.24.5 EASYDIAGNOSIS BIOMEDICINE RECENT DEVELOPMENTS/UPDATES 162
6.25 BEIJING HOTGEN BIOTECH 163
6.25.1 BEIJING HOTGEN BIOTECH CORPORATION INFORMATION 163
6.25.2 BEIJING HOTGEN BIOTECH DESCRIPTION AND BUSINESS OVERVIEW 164
6.25.3 BEIJING HOTGEN BIOTECH COVID-19 RAPID ANTIGEN TEST KITS SALES, REVENUE AND GROSS MARGIN (2020-2022) 165
6.25.4 BEIJING HOTGEN BIOTECH COVID-19 RAPID ANTIGEN TEST KITS PRODUCT PORTFOLIO 165
6.25.5 BEIJING HOTGEN BIOTECH RECENT DEVELOPMENTS/UPDATES 167
6.26 ASSURE TECH 168
6.26.1 ASSURE TECH CORPORATION INFORMATION 168
6.26.2 ASSURE TECH DESCRIPTION AND BUSINESS OVERVIEW 169
6.26.3 ASSURE TECH COVID-19 RAPID ANTIGEN TEST KITS SALES, REVENUE AND GROSS MARGIN (2020-2022) 169
6.26.4 ASSURE TECH COVID-19 RAPID ANTIGEN TEST KITS PRODUCT PORTFOLIO 170
6.26.5 ASSURE TECH RECENT DEVELOPMENTS/UPDATES 172
6.27 HANGZHOU ALLTEST BIOTECH 172
6.27.1 HANGZHOU ALLTEST BIOTECH CORPORATION INFORMATION 172
6.27.2 HANGZHOU ALLTEST BIOTECH DESCRIPTION AND BUSINESS OVERVIEW 173
6.27.3 HANGZHOU ALLTEST BIOTECH COVID-19 RAPID ANTIGEN TEST KITS SALES, REVENUE AND GROSS MARGIN (2020-2022) 173
6.27.4 HANGZHOU ALLTEST BIOTECH COVID-19 RAPID ANTIGEN TEST KITS PRODUCT PORTFOLIO 174
6.27.5 HANGZHOU ALLTEST BIOTECH RECENT DEVELOPMENTS/UPDATES 177
6.28 ACON BIOTECH 177
6.28.1 ACON BIOTECH CORPORATION INFORMATION 178
6.28.2 ACON BIOTECH DESCRIPTION AND BUSINESS OVERVIEW 178
6.28.3 ACON BIOTECH COVID-19 RAPID ANTIGEN TEST KITS SALES, REVENUE AND GROSS MARGIN (2020-2022) 179
6.28.4 ACON BIOTECH COVID-19 RAPID ANTIGEN TEST KITS PRODUCT PORTFOLIO 179
6.28.5 ACON BIOTECH RECENT DEVELOPMENTS/UPDATES 180
6.29 BGI GENOMICS 181
6.29.1 BGI GENOMICS CORPORATION INFORMATION 181
6.29.2 BGI GENOMICS DESCRIPTION AND BUSINESS OVERVIEW 182
6.29.3 BGI GENOMICS COVID-19 RAPID ANTIGEN TEST KITS SALES, REVENUE AND GROSS MARGIN (2020-2022) 182
6.29.4 BGI GENOMICS COVID-19 RAPID ANTIGEN TEST KITS PRODUCT PORTFOLIO 183
6.29.5 BGI GENOMICS RECENT DEVELOPMENTS/UPDATES 183
6.30 LEPU MEDICAL TECHNOLOGY 185
6.30.1 LEPU MEDICAL TECHNOLOGY CORPORATION INFORMATION 185
6.30.2 LEPU MEDICAL TECHNOLOGY DESCRIPTION AND BUSINESS OVERVIEW 186
6.30.3 LEPU MEDICAL TECHNOLOGY COVID-19 RAPID ANTIGEN TEST KITS SALES, REVENUE AND GROSS MARGIN (2020-2022) 187
6.30.4 LEPU MEDICAL TECHNOLOGY COVID-19 RAPID ANTIGEN TEST KITS PRODUCT PORTFOLIO 187
6.30.5 LEPU MEDICAL TECHNOLOGY RECENT DEVELOPMENTS/UPDATES 188
6.31 JINWOFU BIOENGINEERING TECHNOLOGY 189
6.31.1 JINWOFU BIOENGINEERING TECHNOLOGY CORPORATION INFORMATION 189
6.31.2 JINWOFU BIOENGINEERING TECHNOLOGY DESCRIPTION AND BUSINESS OVERVIEW 190
6.31.3 JINWOFU BIOENGINEERING TECHNOLOGY COVID-19 RAPID ANTIGEN TEST KITS SALES, REVENUE AND GROSS MARGIN (2020-2022) 191
6.31.4 JINWOFU BIOENGINEERING TECHNOLOGY COVID-19 RAPID ANTIGEN TEST KITS PRODUCT PORTFOLIO 192
6.31.5 JINWOFU BIOENGINEERING TECHNOLOGY RECENT DEVELOPMENTS/UPDATES 193
6.32 PHASE SCIENTIFIC 194
6.32.1 PHASE SCIENTIFIC CORPORATION INFORMATION 194
6.32.2 PHASE SCIENTIFIC DESCRIPTION AND BUSINESS OVERVIEW 194
6.32.3 PHASE SCIENTIFIC COVID-19 RAPID ANTIGEN TEST KITS SALES, REVENUE AND GROSS MARGIN (2020-2022) 195
6.32.4 PHASE SCIENTIFIC COVID-19 RAPID ANTIGEN TEST KITS PRODUCT PORTFOLIO 195
6.32.5 PHASE SCIENTIFIC RECENT DEVELOPMENTS/UPDATES 198
7 COVID-19 RAPID ANTIGEN TEST KITS MANUFACTURING COST ANALYSIS 200
7.1 COVID-19 RAPID ANTIGEN TEST KITS KEY RAW MATERIALS ANALYSIS 200
7.1.1 KEY RAW MATERIALS 200
7.1.2 KEY SUPPLIERS OF RAW MATERIALS 200
7.2 PROPORTION OF MANUFACTURING COST STRUCTURE 203
7.3 COVID-19 RAPID ANTIGEN TEST KITS INDUSTRIAL CHAIN ANALYSIS 204
8 MARKETING CHANNEL, DISTRIBUTORS AND CUSTOMERS 205
8.1 MARKETING CHANNEL 205
8.2 COVID-19 RAPID ANTIGEN TEST KITS DISTRIBUTORS LIST 206
8.3 COVID-19 RAPID ANTIGEN TEST KITS CUSTOMERS 208
9 COVID-19 RAPID ANTIGEN TEST KITS MARKET DYNAMICS 211
9.1 COVID-19 RAPID ANTIGEN TEST KITS INDUSTRY TRENDS 211
9.2 COVID-19 RAPID ANTIGEN TEST KITS MARKET DRIVERS 211
9.3 COVID-19 RAPID ANTIGEN TEST KITS MARKET CHALLENGES 212
9.4 COVID-19 RAPID ANTIGEN TEST KITS MARKET RESTRAINTS 212
10 GLOBAL MARKET FORECAST 213
10.1 COVID-19 RAPID ANTIGEN TEST KITS MARKET ESTIMATES AND PROJECTIONS BY TYPE 213
10.1.1 GLOBAL FORECASTED SALES OF COVID-19 RAPID ANTIGEN TEST KITS BY TYPE (2023-2028) 213
10.1.2 GLOBAL FORECASTED REVENUE OF COVID-19 RAPID ANTIGEN TEST KITS BY TYPE (2023-2028) 214
10.2 COVID-19 RAPID ANTIGEN TEST KITS MARKET ESTIMATES AND PROJECTIONS BY APPLICATION 214
10.2.1 GLOBAL FORECASTED SALES OF COVID-19 RAPID ANTIGEN TEST KITS BY APPLICATION (2023-2028) 214
10.2.2 GLOBAL FORECASTED REVENUE OF COVID-19 RAPID ANTIGEN TEST KITS BY APPLICATION (2023-2028) 215
10.3 COVID-19 RAPID ANTIGEN TEST KITS MARKET ESTIMATES AND PROJECTIONS BY REGION 216
10.3.1 GLOBAL FORECASTED SALES OF COVID-19 RAPID ANTIGEN TEST KITS BY REGION (2023-2028) 216
10.3.2 GLOBAL FORECASTED REVENUE OF COVID-19 RAPID ANTIGEN TEST KITS BY REGION (2023-2028) 217
11 RESEARCH FINDINGS AND CONCLUSION 218
12 METHODOLOGY AND DATA SOURCE 219
12.1 METHODOLOGY/RESEARCH APPROACH 219
12.1.1 RESEARCH PROGRAMS/DESIGN 219
12.1.2 MARKET SIZE ESTIMATION 220
12.1.3 MARKET BREAKDOWN AND DATA TRIANGULATION 221
12.2 DATA SOURCE 222
12.2.1 SECONDARY SOURCES 222
12.2.2 PRIMARY SOURCES 223
12.3 AUTHOR LIST 225
12.4 DISCLAIMER 226